Serum resistin level is a predictor of ovarian response in in vitro fertilisation cycle

Acta Obstetricia et Gynecologica Scandinavica

Volumn 86, Issue 8, 2007, Pages 963-967

  Chen, Yu Chieh ^b   Tsai, Eing Mei ^a,b   Chen, Hung Sheng ^b   Liu, Yung Hsien ^b   Lee, Chien Hung ^c   Chou, Fan Hao ^c   Chen, I Ju ^b   Chen, Su Yin ^b   Jong, Shiang Bin ^b   Chan, Te Fu ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

In vitro fertilisation embryo transfer; Ovarian response; Polycystic ovarian syndrome; Resistin

Indexed keywords

GONADOTROPIN; RESISTIN;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CASE CONTROL STUDY; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO TRANSFER; ENDOMETRIOSIS; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; INFLAMMATION; MENSTRUAL CYCLE; OOCYTE; OVARY; OVARY POLYCYSTIC DISEASE; PELVIC INFLAMMATORY DISEASE; PREGNANCY RATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; CASE-CONTROL STUDIES; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; OOCYTES; POLYCYSTIC OVARY SYNDROME; PREGNANCY; RESISTIN;

EID: 34547162806     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340701434492     Document Type: Article

References (21)

1. Stephen EH, Chandra A. Declining estimates of infertility in the United States: 1982-2002. Fertil Steril. 2006;86:516-23.
2. Society for Assisted Reproductive Technology, American Society for Reproductive Medicine. Assisted reproductive technology in the United States: 2000 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril. 2004;81:1207-20.
3. Toner JP, Philput CB, Jones GS, Muasher SJ. Basal follicle-stimulating formone level is a better predictor of in vitro fertilization performance than age. Fertil Steril. 1991;55:784-91.
4. Creus M, Penarrubia J, Fabregues F, Vidal E, Carmona F, Casamitjana R, et al. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod. 2000;15:2341-6.
5. Brannian JD, Schmidt SM, Kreger DO, Hansen KA. Baseline non-fasting serum leptin concentration to body mass index ratio is predictive of IVF outcomes. Hum Reprod. 2001;16:1819-26.
6. Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY, et al. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA. 2001;98:502-6.
7. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, et al. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 2000;19:4046-55.
8. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409:307-12.
9. Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metabol. 2002;13:18-22.
10. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, et al. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptorgamma action in humans. Diabetes. 2001;50:2199-202.
11. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun. 2003;300:472-6.
12. Lehrke M, Reilly MP, Millington SC, Lqbal N, Rader DJ, Lazar MA. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med. 2005;1:161-8.
13. Stejskal D, Adamovská S, Bartek J, Juráková R, Prosková J. Resistin-concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed Papers. 2003;147:63-9.
14. Land JA, Evers JL. Chlamydia infection and subfertility. Best Pract Res Clin Obstet Gynaecol. 2002;16:901-12.
15. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19-25.
16. Panidis D, Koliakos G, Kourtis A, Farmakiots D, Mouslech T, Rousso D. Serum resistin levels in women with polycystic ovary syndrome. Fertil Steril. 2004;81:361-6.
17. Seow KM, Juan CC, Wu YL, Hsu YP, Yang WM, Tsai YL, et al. Serum and adipocyte resistin in polycystic ovarian syndrome with insulin resistance. Hum Reprod. 2004;19:48-53.
18. Cheong YC, Shelton JB, Laird SM, Richmond M, Kudesia G, Li TC, et al. IL-1, IL-6 and TNF-alpha concentrations in the peritoneal fluid of women with pelvic adhesions. Hum Reprod. 2002;17:69-75.
19. Lee KS, Joo BS, Na YJ, Yoon MS, Choi OH, Kim WW. Relationships between concentrations of tumor necrosis factor-alpha and nitric oxide in follicular fluid and oocyte quality. J Assist Reprod Genet. 2000;17:222-8.
20. Pellicer A, Albert C, Garrido N, Navarro J, Remohi J, Simon C. The patholophysiology of endometriosis-associated infertility: follicular environment and embryo quality. J Reprod Fertil Suppl. 2000;55:109-19.
21. Stejskal D, Adamovská S, Bartek J, Juráková R, Prosková J. Resistin-concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed Papers. 2003;147:63-9.